Economies around the world formally join the COVID-19 vaccine global acquisition mechanism to help the world fight the Epidemic
The 64 higher-income economies have already joined the
COVID-19 vaccine global access mechanism, and another 38 economies are expected
to sign up in the next few days.
These self-funded economies (including the 29 economies
participating in the “European Team” as part of the agreement with the European
Commission) will be in line with 92 countries eligible to receive financial
support through the GAVI COVID-19 vaccine advance market commitment. Income
economies join hands.
This means that a total of 156 economies (accounting for
nearly two-thirds of the global population) are currently committed or eligible
to receive vaccines through the global access mechanism. Click here to view the
list of participating economies.
Which high income economies have joined GAVI?
64 high-income economies have joined the COVID-19 vaccine global access mechanism. This global initiative brings together governments and manufacturers to ensure that the COVID-19 vaccine is finally available to those who need it most, no matter who they are or where they are.
The 64 companies include 35 economies and the European Commission, which will purchase vaccines on behalf of the 27 EU member states as well as Norway and Iceland.
By pooling financial and scientific resources, these
participating economies will be able to ensure that they are protected from the
failure of any vaccine candidates and obtain successful vaccines in a
cost-effective and targeted manner.
Are Low Income Countries also included in GAVI?
In addition to these 64 members, the global access mechanism will also cover 92 low-income and middle-income economies that are eligible for vaccine procurement support through the Global Alliance for Vaccines and Immunization COVID-19 vaccine pre-market commitment.
These countries are
financing tools for purchasing vaccines. This means that 156 economies, which
account for about 64% of the world’s total population, have either committed to
join the COVID-19 vaccine global access mechanism, or are eligible for its
support, and there will be more in the future.
With the conclusion of the commitment agreement, the COVID-19 vaccine global access mechanism will now begin to sign formal agreements with vaccine manufacturers and development agencies as working partners in the vaccine field to ensure that sufficient doses are obtained to end the acute phase of the pandemic by the end of 2021.
In addition, efforts are being made
to raise funds for research and development and the advance market commitment
of COVID-19 vaccines through the Global Alliance for Vaccines and Immunization
to purchase vaccines for low-income countries.
Dr. Seth Berkley, CEO of the Global Alliance for Vaccines and Immunization, which is responsible for coordinating the global access mechanism for COVID-19 vaccines, said:
"The access to COVID-19 vaccines is underway: governments from all continents have chosen to work together to not only guarantee vaccines for their people, And also to help ensure that vaccines are available to the most vulnerable people around the world.
We today announced our commitment to the global access mechanism for COVID-19 vaccines and are also building a historic partnership with the industry.
With these, once safe
and effective vaccines are available , We have a better chance to end the acute
phase of this pandemic."
Is COVID Vaccine Global Access part of vaccine pillar of COVID tool acceleration plan?
The COVID-19 vaccine global access mechanism is part of the
vaccine pillar of the COVID-19 tool acceleration plan. It is jointly led by the
Epidemic Prevention Innovation Alliance, the Global Alliance for Vaccines and
Immunization, and the World Health Organization. Cooperation between foundations,
the World Bank, civil society organizations and other institutions.
Once licensed and approved, the distribution of vaccines will
be guided by the distribution framework issued by WHO today. The framework
follows the principles of fair and equal access to ensure that participating
economies will not be left behind. The WHO immunization strategy advisory
expert group recently released a framework of values to lay the foundation
for subsequent guidance documents and vaccine use policies for target populations.
WHO Director-General Dr. Tedros said: “COVID-19 is an
unprecedented global crisis that requires an unprecedented global response.
Vaccine nationalism will only perpetuate the disease and delay the global
recovery. Through the COVID-19 vaccine The joint efforts of the Global Access
Mechanism are not charity. Controlling the pandemic and accelerating the global
economic recovery is in the best interest of every country."
Now, the commitment of fully self-financing economies will
release important funding and demand guarantees to expand production and ensure
the number of vaccines required by the global access mechanism. The Epidemic
Prevention Innovation Alliance is leading the research and development of
COVID-19 vaccines, with the goal of developing at least three safe and
effective vaccines for use by economies participating in the Global Access
Mechanism. Currently, the Epidemic Prevention Innovation Alliance is supporting
9 candidate vaccines, of which 8 are undergoing clinical trials.
Dr. Richard Hatchett, CEO of the Epidemic Prevention
Innovation Alliance, said: “The international community’s joint response to
this pandemic is a landmark moment in the history of public health. The global
spread of COVID-19 means that only through simultaneous fair access to rescue
With the new COVID-19 vaccine of life, we can hope to end this pandemic.
Countries come together in this way because they have the common goal and
determination to end the acute phase of the pandemic. We must now play a role
in the global response Vaccine manufacturers with essential roles work closely
together to form the necessary agreements to achieve the core goal of global
access to COVID-19 vaccines, which is to provide 2 billion doses of vaccine by
the end of 2021. Today, for the benefit of everyone, we are moving towards this
goal A big step forward."
The success of the global acquisition of COVID-19 vaccine
depends not only on the participation of economies in the global acquisition
mechanism and the commitment of vaccine manufacturers, but also on filling the
key funding gap for vaccine research and development and the Global Alliance
for Vaccines and Immunization COVID-19 vaccine advance market commitments.
Support low-income economies to participate in global access mechanisms.
 |
| World Economies Fighting COVID Pandemic |
So far, governments, vaccine manufacturers (in addition to
their own research and development), various organizations and individuals have
pledged to provide 1.4 billion US dollars for vaccine research and development,
but in addition to providing 300 million US dollars for WHO’s “solidarity”
trial, they have also There is an urgent need for another 700-800 million U.S.
dollars to continue related work.
The Global Alliance for Vaccines and Immunization COVID-19
vaccine advance market pledge has raised approximately US$700 million from
sovereign donors, charities and the private sector, and the initial goal is to
require US$2 billion in seed funding by the end of 2020. Funding this mechanism
is essential to ensure that the ability to pay does not become a barrier to
obtaining the COVID-19 vaccine. Given the unabated pandemic and its impact,
lack of access to vaccines will leave most parts of the world unprotected.
The commitment agreement also requires the governments of
higher-income countries to advance funds for reserve doses by October 9, 2020.
These funds will be used to accelerate the expansion of vaccine production to
ensure 2 billion doses of vaccine sufficient to vaccinate 1 billion people
(assuming this vaccine needs to be vaccinated twice). Further details on these
advance payments can be found in the introduction material of the Global
Vaccine Alliance COVID-19 Vaccine Global Access Mechanism.
In addition to purchasing for participating economies, the
global access mechanism will also maintain a buffer dose for emergency and
humanitarian use.
Views of participating countries
Canadian Prime Minister Justin Trudeau said: "COVID-19
is causing serious health concerns to people all over the world. This is why
Canada is committed to working with partners around the world to end this
pandemic. Access to safety is fair, timely and affordable. An effective
COVID-19 vaccine is essential to help protect people’s health. Canada supports
the goals and principles of the COVID-19 vaccine global access mechanism and
believes that it is the only global collective procurement mechanism for
countries to cooperate on this major cause. China is Part of this important
global response."
New Zealand’s Prime Minister Ardern said: “New Zealand’s
commitment to the global access mechanism for the COVID-19 vaccine also
supports other countries in obtaining the COVID-19 vaccine.”
Dr. Edwin G. Dikoloti, Minister of Health and Health of
Botswana, said: “The idea of global access to the COVID-19 vaccine and equal
access to the COVID-19 vaccine regardless of ability to pay is not only a moral
imperative, but also the only response to this pandemic. A pragmatic solution.
Protecting everyone is the only way to return our world-our trade, tourism,
travel, commerce-to normal. We urge countries that have not yet joined to join
in. Let us work together to protect each other."
Ethiopia’s Minister of Health, Dr. Lia Tadesse, said:
“Vaccinations can save lives. Investing in immunization infrastructure can help
strengthen the health system. We have seen this time and time again in the
process of working with the Global Alliance for Vaccines and Alliance partners.
As part of the COVID-19 vaccine global access mechanism and advance market
commitment, we can continue this work to protect our citizens and the world
from the effects of COVID-19."
Ekaterine Tikaradze, Minister of Health of Georgia, said:
"To promote global access to COVID-19 vaccines, the world is uniting,
proving that we are stronger together and that we can overcome this pandemic.
Georgia will join the global access mechanism for our citizens Provide the best
access to safe vaccines. By doing so, we also ensure that health care workers
and other high-risk groups around the world have access to these life-saving
tools to help contain the pandemic so that everyone can recover and recover.
reconstruction."
Dr. Basel Humoud Al-Sabah, Minister of Health of the State of
Kuwait, said: “Joining the COVID-19 vaccine global access mechanism is not a
difficult decision. This not only enables Kuwaiti citizens to obtain the
COVID-19 vaccine, but also means that our friends and partners abroad also
Access to vaccines. We need a global solution to deal with the global pandemic.
We believe that the Global Access Mechanism is the solution."
Dag-Inge Ulstein, Norwegian Minister of International
Development, said: “We believe that international cooperation and global
efforts are the key. We must continue our efforts to obtain equitable access to
vaccines, testing reagents and treatments. To overcome the COVID-19 pandemic,
rich countries need to be fast And act boldly to provide vaccines and
treatments to those who cannot afford to pay for themselves. With the commitment
to the global access mechanism, we are moving in the right direction."
Dr. Ahmed Mohammed Obaid Al Saidi, Minister of Health of the
Sultanate of Oman, said: “This is a very important initiative that can provide
us with a path out of the acute phase of the pandemic and return to normal. For
the benefit of all of us, I urge all those who have not yet joined Countries
join in. Cooperation is much better than doing things independently."
Partner's comment
Mr. Sai D. Prasad, Chairman of the Network of Vaccine
Manufacturers in Developing Countries, said: “The history of vaccines will be
defined by our response to COVID-19. The Global Access Mechanism for COVID-19
Vaccines is the center of the global response. Companies are in the midst of
vaccine development and production. At the forefront, billions of vaccines can
be supplied in the next few years. The global access mechanism will have a
major impact on the lives and livelihoods of all countries, and promote
countries to speed up the return to normal. The network of vaccine
manufacturers in developing countries cooperates fully with their partners to
strengthen global public Hygiene mission, let no one be left behind."
Thomas Cueni, Director General of the International
Federation of Pharmaceutical Manufacturers Associations said: "It is very
encouraging to see so many countries move from negotiations to full
commitments. Only when rich and poor countries are united can the global access
mechanism work and achieve Fair access. Today, vaccine manufacturers with the
unique skills and expertise to increase production capacity to unprecedented
levels are ready to meet the challenge of providing 2 billion doses of the
currently unknown COVID-19 vaccine. This is no easy task because it requires
Doubled the existing capacity in record time. Today we have taken an important
step forward, which is also a historic sign of solidarity. This solidarity
enables us to end the acute phase of this pandemic; We are proud to participate
in this unique effort to leave no one behind."
Jagan Chapagain, secretary-general of the International
Federation of Red Cross and Red Crescent Societies, said: “We must work
together through the COVID-19 vaccine global access mechanism to ensure that
the COVID-19 vaccine is distributed and delivered to those who need it most,
not just Only those who can afford it. We have a moral and public
responsibility to protect the poor in rural communities, just like the rich in
cities, the elderly in nursing homes, and the young in refugee camps. We humans
The power of and the success of the global access mechanism will depend on how
we work together to protect the most vulnerable among us."
Save the Children CEO Kevin Watkins said: "Global
cooperation must become the cornerstone of the global response to COVID-19. The
COVID-19 vaccine global access mechanism may help ensure universal and fair
access to future COVID-19 vaccines. To do this On one point, we need to ensure
that people in low- and middle-income countries get their share and get the
vaccines they need to help overcome the greatest public health and child rights
crisis facing our generation."
UNICEF Executive Director Henrietta Fore said: “Seeing that
all parties are so united in the face of the COVID-19 crisis, we believe that
we can work together to ensure the fair delivery of the COVID-19 vaccine
globally. UNICEF’s supply chain With presence all over the world and staff in
190 countries, we are proud to support this historic effort."
Notes to the editor
Explanatory materials about the global access mechanism for
the COVID-19 vaccine can be found on the website of the Global Alliance for
Vaccines and Immunization, and the Q&A from Seth Berkley, CEO of the Global
Alliance for Vaccines and Immunization, can be viewed here.
Complete self-financing economies that have submitted binding
commitment agreements and non-binding confirmations of intent to participate,
and 92 low- and middle-income countries eligible to join the Global Alliance
for Vaccines and Immunization COVID-19 vaccine pre-market commitments The list
can be found here.
About the Global Alliance for Vaccines
The Global Alliance for Vaccination and Immunization is a
government-private partnership project to help half of the world’s children
vaccinate to prevent some of the deadliest diseases. Since its establishment in
2000, the Global Alliance for Vaccines and Immunization has helped to vaccinate
a whole generation, that is, more than 760 million children, avoid more than 13
million deaths, and help halve child mortality in 73 developing countries. The
Global Alliance for Vaccines and Immunization also supports the health system
and funds global stockpiles of vaccines for Ebola, cholera, meningitis and
yellow fever, thus playing a key role in improving global health security.
After 20 years of progress, the Global Alliance for Vaccines and Immunization
is now committed to protecting the next generation, helping unvaccinated
children who are left behind, using innovative financing methods and the latest
technologies from drones to biometrics to save millions of lives , To prevent
outbreaks before they spread, and to help countries embark on a path of
self-sufficiency. Learn more on www.gavi.org and connect with us on Facebook
and Twitter.
The Global Alliance for Vaccines and Immunization brings
together developing and donor governments, the World Health Organization,
UNICEF, the World Bank, the vaccine industry, technical institutions, civil
society, the Bill and Melinda Gates Foundation and other private sector
partners. Click here to see the full list of donor governments and other major
organizations that fund the work of the Global Alliance for Vaccines and
Immunization.
About Epidemic Prevention Innovation Alliance
The Epidemic Prevention Innovation Alliance is an innovative
partnership between public, private, charitable and civil organizations
launched in Davos in 2017 to develop vaccines to prevent future epidemics. In
response to the COVID-19 epidemic, the Epidemic Prevention Innovation Alliance
took urgent action and coordinated with the WHO. The Epidemic Prevention
Innovation Alliance has initiated nine partnerships to develop a new
coronavirus vaccine. These plans are taking advantage of the rapid response
platforms and new partnerships that the alliance already supports.
Prior to the COVID-19 outbreak, the top diseases that the
Epidemic Prevention Innovation Alliance focused on included Ebola virus, Lassa
virus, Middle East respiratory syndrome coronavirus, Nipah virus, Rift Valley
fever and Chikungunya virus. The Epidemic Prevention Innovation Alliance has
also invested in platform technologies that can be used for rapid vaccine and
immune prevention development against unknown pathogens (Disease X).
About the World Health Organization
The World Health Organization plays a global leadership role
in the field of public health within the United Nations system. Founded in
1948, WHO has more than 150 offices around the world, working with 194 member
states from six regions to promote health, keep the world safe, and serve
vulnerable groups. Our goal for 2019-2023 is to ensure that one billion more
people will benefit from universal health coverage, one billion more people
will be better protected in the face of health emergencies, and one billion
more people will have improved health and well-being.
To learn more about COVID-19 and public health advice to
protect yourself from the coronavirus, please visit www.who.int/zh and follow
on Twitter, Facebook, Instagram, LinkedIn, TikTok, Pinterest, Snapchat and
YouTube WHO.
Regarding the Acceleration Plan for Access to COVID-19 Tools
The Acceleration Program for Access to COVID-19 Tools is a
pioneering new global cooperation initiative aimed at accelerating the
development, production, and fair access to COVID-19 testing methods,
treatments, and vaccines. In April 2020, WHO, the European Commission, France
and the Bill and Melinda Gates Foundation jointly initiated the establishment
in response to the call of the leaders of the G20.
The Acceleration Plan for Access to COVID-19 Tools is not a
decision-making body or a new organization, but is dedicated to accelerating
collaborative efforts between existing organizations to end the pandemic. This
is a collaborative framework that aims to enable key actors to work together
through accelerated development, fair distribution, and expanded delivery of
test kits, treatments, and vaccines to end the pandemic as soon as possible,
thereby protecting the health system and restoring it in the near future Society
and economy. It draws on the leading experience of the Global Health
Organization, which is responding to the world’s toughest health challenges.
Through joint efforts, these organizations can achieve more ambitious new
results against COVID-19. The participating members jointly pledge to ensure
that everyone has access to all the tools needed to defeat COVID-19, and work
together to achieve this goal in an unprecedented partnership.
The Acceleration Program for Acquiring COVID-19 Tools has
four areas of work: diagnostic methods, treatment methods, vaccines, and
connection to the health system. The workflow for acquisition and distribution
is cross-cutting.
May Refer also:
0 Comments
Thanks for your comment!